Based on analysis of the German cohort of patients from the PROGNOSIS study, we demonstrate that use of sFlt-1/PlGF ratios of ≤ 38 is likely to reduce unnecessary hospitalization for women with suspected preeclampsia. Here, PGF is linked to preeclampsia.